For the first time, our study used multiple databases to uncover the role of GJB3 in cancer and its impact on the immune microenvironment, verified its role in lung adenocarcinoma, and explored its clinical effectiveness in guiding drug treatment. This evidence concerns the gene GJB3 and lung adenocarcinoma.